174 related articles for article (PubMed ID: 30046699)
1. Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?
Rabbolini DJ; Gardiner EE; Morel-Kopp MC; Dunkley S; Jahangiri A; Lee CS; Stevenson WS; Ward CM
Res Pract Thromb Haemost; 2017 Oct; 1(2):291-295. PubMed ID: 30046699
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia.
Tantawy AAG; Elsherif NHK; Ebeid FS; El-Gamal RAE; Ismail EAR; Kenny MA; Morcos MBE
J Thromb Thrombolysis; 2023 Feb; 55(2):243-251. PubMed ID: 36479670
[TBL] [Abstract][Full Text] [Related]
3. Study of a humanized inhibitory anti-platelet glycoprotein VI phage antibody from a phage antibody library.
Liu Q; Zhang C; Yu L; Shi Y; Zhang L; Peng J; Ji X; Hou M
Hematology; 2016 Jan; 21(1):60-7. PubMed ID: 26330203
[TBL] [Abstract][Full Text] [Related]
4. Association between endometriosis, infertility and autoimmune antiplatelet glycoprotein VI antibodies in two patients.
Loyau S; Bauters A; Trillot N; Garcia C; Cougoul P; Pol H; Paris C; Robin G; Rubod C; Payrastre B; Jandrot-Perrus M; Voisin S; Dupont A
Platelets; 2023 Dec; 34(1):2226756. PubMed ID: 37350057
[TBL] [Abstract][Full Text] [Related]
5. Anti-glycoprotein autoantibodies are related to bleeding severity in children with newly diagnosed ITP and very low platelet counts.
Dong S; Gu H; Zhang J; Fu L; Xie X; Ma J; Ma J; Chen Z; Wu R
Pediatr Blood Cancer; 2023 Feb; 70(2):e30094. PubMed ID: 36377718
[TBL] [Abstract][Full Text] [Related]
6. Presence of platelet-associated anti-glycoprotein (GP)VI autoantibodies and restoration of GPVI expression in patients with GPVI deficiency.
Akiyama M; Kashiwagi H; Todo K; Moroi M; Berndt MC; Kojima H; Kanakura Y; Tomiyama Y
J Thromb Haemost; 2009 Aug; 7(8):1373-83. PubMed ID: 19522742
[TBL] [Abstract][Full Text] [Related]
7. Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura.
Gardiner EE; Al-Tamimi M; Mu FT; Karunakaran D; Thom JY; Moroi M; Andrews RK; Berndt MC; Baker RI
J Thromb Haemost; 2008 Jul; 6(7):1175-82. PubMed ID: 18485087
[TBL] [Abstract][Full Text] [Related]
8. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.
Boylan B; Chen H; Rathore V; Paddock C; Salacz M; Friedman KD; Curtis BR; Stapleton M; Newman DK; Kahn ML; Newman PJ
Blood; 2004 Sep; 104(5):1350-5. PubMed ID: 15150079
[TBL] [Abstract][Full Text] [Related]
9. An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis.
Nurden P; Tandon N; Takizawa H; Couzi L; Morel D; Fiore M; Pillois X; Loyau S; Jandrot-Perrus M; Nurden AT
J Thromb Haemost; 2009 Sep; 7(9):1541-9. PubMed ID: 19583823
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia.
Zheng SS; Ahmadi Z; Leung HHL; Wong R; Yan F; Perdomo JS; Chong BH
Haematologica; 2022 Sep; 107(9):2195-2205. PubMed ID: 35199503
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration.
Kojima H; Moroi M; Jung SM; Goto S; Tamura N; Kozuma Y; Suzukawa K; Nagasawa T
J Thromb Haemost; 2006 Nov; 4(11):2433-42. PubMed ID: 17059472
[TBL] [Abstract][Full Text] [Related]
12. Recognition of the human antibody-mediated platelet destruction in adult ITP patients by C-reactive protein.
Pan JQ; Wang W; Wang ML; Li XY; Wang JH; Zhao WW; Tian YY; Dong XS; Jiang YF
Int J Clin Exp Pathol; 2017; 10(10):10176-10185. PubMed ID: 31966351
[TBL] [Abstract][Full Text] [Related]
13. CLINICAL RELEVANCE OF EXTENDED PLATELET INDICES IN THE DIAGNOSIS OF IMMUNE THROMBOCYTOPENIA.
Arshad A; Mukry SN; Shamsi TS
Acta Clin Croat; 2021 Dec; 60(4):665-674. PubMed ID: 35734488
[TBL] [Abstract][Full Text] [Related]
14. The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test.
Vrbensky JR; Moore JE; Arnold DM; Smith JW; Kelton JG; Nazy I
J Thromb Haemost; 2019 May; 17(5):787-794. PubMed ID: 30801909
[TBL] [Abstract][Full Text] [Related]
15. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
16. Persistent Relapsing Immune Thrombocytopenia Following COVID-19 Infection.
Boehm BA; Packer CD
Cureus; 2022 Jul; 14(7):e27133. PubMed ID: 36004011
[TBL] [Abstract][Full Text] [Related]
17. Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura.
Taub JW; Warrier I; Holtkamp C; Beardsley DS; Lusher JM
Am J Hematol; 1995 Feb; 48(2):104-7. PubMed ID: 7847322
[TBL] [Abstract][Full Text] [Related]
18. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.
Al-Tamimi M; Mu FT; Moroi M; Gardiner EE; Berndt MC; Andrews RK
Platelets; 2009 May; 20(3):143-9. PubMed ID: 19437330
[TBL] [Abstract][Full Text] [Related]
19. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
Bakchoul T; Sachs UJ
Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
[TBL] [Abstract][Full Text] [Related]
20. Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP).
Neschadim A; Branch DR
Curr Protoc Immunol; 2016 Apr; 113():15.30.1-15.30.13. PubMed ID: 27038460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
